16S ribosomal RNA A-site (16S rRNA A-site)

The 16S ribosomal RNA (rRNA) A-site is a highly conserved region within the 30S small ribosomal subunit of bacteria that plays a fundamental role in the decoding of mRNA during protein synthesis (PubMed: PMC107340). It functions as a checkpoint to ensure the fidelity of translation by monitoring the interaction between the mRNA codon and the tRNA anticodon. Aminoglycoside antibiotics, such as gentamicin, target this region by binding specifically to the internal loop of the A-site (PubMed: PMC3163961). This binding forces the conserved adenine residues A1492 and A1493 into an "extrahelical" conformation, which reduces the energy barrier for non-cognate tRNA binding. Consequently, the ribosome produces defective proteins, leading to membrane damage and bacterial cell death (StatPearls: Aminoglycosides, 2023). While highly effective against Gram-negative bacteria, the structural similarity between bacterial 16S rRNA and human mitochondrial 12S rRNA can lead to off-target effects. These off-target interactions result in clinical toxicities such as hearing loss and kidney damage (NIH: LiverTox, Gentamicin). Resistance to drugs targeting this site often arises through enzymatic modification of the drug or methylation of the rRNA itself.

Other names

Decoding region30S ribosomal subunit A-site16S rRNA decoding centerAminoacyl-tRNA binding site

Aminoglycosides bind to the A-site of the 16S rRNA within the 30S ribosomal subunit, inducing a conformational change in residues A1492 and A1493 (PubMed: PMC3163961). This change mimics the state of correct codon-anticodon pairing, leading to the incorporation of incorrect amino acids (mistranslation) and the eventual inhibition of protein synthesis (StatPearls: Aminoglycosides, 2023).